Search: 2018 EU Meeting Faculty
Results 1 - 7 of 7

Adrian Aldcroft

Editor
BMJ Open


Bio: Adrian Aldcroft is the Editor of BMJ Open, an open access general medical journal that promotes transparency in the publication process by publishing reviewer reports and previous versions of the manuscript alongside the published article. Adrian has also worked as a staff editor on PLOS ONE and as a Senior Executive Editor on the BMC Series. Prior to working in publishing, Adrian spent several years at The University of Western Ontario conducting research using fMRI to map the functional areas of the visual cortex.

Lise Baltzer

Director Global Publications, Global Medical Affairs
Novo Nordisk A/S


Type of Company:
Pharmaceutical
Professional Degrees: MBA

Patrice Becker

Global Scientific Communications Director
Medtronic


Bio: Patrice is a medical device industry expert with 25 years of experience in Clinical and Medical Affairs. He holds a Masters Degree in Pharmacology and a Masters Degree in Business Administration for Pharmaceutical and Biomedical Companies. After he joined Sofradim/Medtronic in 1998, he took the lead and established the clinical research department. Since 2012, he is the Leader of the Scientific Communication for Abdominal and Robotic Surgery. Prior to joining Medtronic, he spent almost 5 years as a clinical research manager at Biomatech, a consulting and testing company focused on medical devices. In addition, Patrice is an expert in numerous standards including ISO 14155, EUCOMED, and is a member of several task forces.

Theodora Bloom

Executive Editor
The BMJ


Bio: Theodora Bloom is executive editor of The BMJ, where her responsibilities include operations in print and online, as well as budgetary, ethical and policy matters. She has worked in biomedical publishing since 1992, initially as an editor on the biology team at Nature, and then on the founding team of Current Biology. After a number of years helping to develop Current Biology and its siblings Structure and Chemistry & Biology, Theo joined the beginnings of the open access movement. As the founding editor of Genome Biology she was closely involved in the birth of the commercial open access publisher BioMed Central, where she remained for several years, ultimately as Editorial Director for Biology. After a spell as a freelance publishing consultant working with a variety of clients, including a medical communications agency, she joined the non-profit open access publisher Public Library of Science (PLOS) in 2008, first as chief editor of PLOS Biology and later as Biology Editorial Director with additional responsibility for PLOS Computational Biology and PLOS Genetics. She also took the lead for PLOS on issues around data access and availability. She chairs the scientific advisory board for EMBL-EBI Literature Services (http://www.ebi.ac.uk/services/literature). Until recently she served on the boards of NAM Publications (www.aidsmap.com) and the Dryad digital repository (www.datadryad.org), and on the Genome Canada Data Sharing Policies Advisory Committee. Theo has a bachelor¿s degree in Natural Sciences and a PhD in developmental cell biology from the University of Cambridge and worked as a postdoctoral fellow at Harvard Medical School, researching cell-cycle regulation, before moving into publishing.

Daniel Bridges

Regional Director - Europe & China
Nucleus Global


Type of Company:
Communications Agency
Professional Degrees: CMPP, MS, PhD
CMPP Certified: (3/2012)

Bio: Dan is currently the Regional Director for Europe and China at Nucleus Global, where he is responsible for the seven medical communication agencies (Articulate Science, Cognito Medical, Health Interactions, Medical Expressions, Meditech Media, Meditech Media China & Scimentum) that support clients across these regions and globally. In his 13 years in medical communications, Dan has specialised in building integrated publication planning offerings in both the clinical and HEOR fields and has led global and affiliate publication plans across multiple therapeutic areas and all stages of the product lifecycle. He has also provided extensive consultancy support to clients in the development of publication SOPs and integration of best practice guidelines. He currently serves on the ISMPP Board of Trustees and was an author on both GPP2 and GPP3. Prior to his medical communications career, Dan gained an MSC in Biochemistry from the University of Bath, UK and a PhD on the clinical use of cannabinoids for neuropathic pain from Imperial College London, UK (in collaboration with Novartis).

Antonio Ciaglia

Policy Manager
International Alliance of Patients' Organizations (IAPO)


Bio: Dr. Antonio Ciaglia is Policy Manager at the International Alliance of Patients' Organizations (IAPO) where he leads policy development and research activities. Antonio holds a PhD in Political Science and has worked as a lecturer at the University of the Witwatersrand, Johannesburg and the University of Portsmouth. He specialises in policy research, health policy, patient information, and the role of civil society actors in policy making. Antonio represents IAPO in international, multi-stakeholder fora within which he collaborates with other patients' organizations, the WHO, regulators, HTA bodies and industry. In IMI-funded research projects, such as IMI-GetReal and IMI-PREFER, Antonio carries out primary and secondary research activities aimed at collecting and providing evidence-based patient perspectives around various aspects related to healthcare decision-making. Antonio's work has appeared on various academic journals with a focus on policy and political science.

Duncan Currie

Maze House Medical Ltd


Bio: Duncan is a medical writer with 22 years experience in large pharmaceutical companies (Pfizer and Lundbeck) and Contract Research Organisations (PRA, Quanticate, and PPD) with a track record of delivering a range of high quality documents within tight deadlines and budgets. He has an academic background with a PhD in Clinical Pharmacology and has conducted research on the effects of drugs of psychomotor function at Dundee and Surrey Universities. Duncan has been working freelance as a medical writer for 6 years and his company, Maze House Medical Ltd, provides predominantly regulatory medical writing services to the pharmaceutical industry. Duncan specialises in authoring and quality control of clinical study reports and serious adverse event narratives but also has experience in writing clinical study protocols, investigator brochures, and other regulatory documents. Duncan also has some medical communications experience having compiled advisory board minutes and also produced a variety of scientific publications over many years.